Providers were recently emailed a postcard about updates to our guidelines and other important information. We encourage you to review these updates at your earliest convenience.
Effective Feb. 1, 2016, prior authorization is changing for afibercept (Eylea) and ranibizumab (Lucentis).
Effective Feb. 1, 2016, carbidopa and levodopa enteral suspension (Duopa) require prior authorization.
Review several changes to InstaMed's electronic remittance advice, effective Oct. 25.
Check out Clinical Pearls recommendations you can integrate into your daily practice.
Effective Jan. 1, changes to the medical necessity review criteria may affect coverage of services for intraoperative neurophysiolgic monitoring (IONM).
If you must submit a pre-authorization request by fax instead of via OneHealthPort, use our standard pre-authorization request fax form.
Generic drug price increases, benzodiazepine discontinuation in long-term users, LEAP trial, and more.
ICD-10 implementation; updated asthma, diabetes, and chlamydia guidelines; pharmacy updates, and more.
Highlights from the Sept. 9 meeting.
Non-Medicare Drug List updated Sept. 29, 2015.
Group Health no longer contracts with Health Dialog, a vendor providing health coaching services. These services are now part of Care Management.
Procedure notifications, updates to Transition of Care policy, ICD-10 information, and more.
For questions about your existing account, call OHP technical support at 1-800-973-4797.
Don't have an account? Visit OneHealthPort for more information.
Notify Us of a Change to Your Practice
Complete the appropriate form and e-mail it to Provider Services.
Online Services Demos
Contractually binding information on this site.
Recommendations for clinicians and patients.